EXPO
Exponent, Inc.
EXPO's fundamentals are strong and it looks cheap: trading at 37x earnings, below its usual 47x. Analysts expect earnings growth.
EXPO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
EXPO's revenue, profitability, cash flow and balance sheet are all currently healthy.
EXPO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 33x | $86.22 | — |
| Cheap | 36x | $82.56 | -4.2% |
| Current | 37x | $86.22 | — |
| Fair | 47x | $109 | +27% |
| Expensive | 55x | $127 | +48% |
Historical ranges are pointers, not guarantees.
EXPO's PE is in its cheap range at 37x. If earnings grow as analysts expect, today's price would be 33x next year's earnings.
EXPO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for EXPO, with profitability improving.
EXPO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.58 | +12% |
| Q3 2026 | $2.31 | +13% |
| Q2 2026 | $2.22 | +12% |
| Q1 2026 | $2.14 | +4.9% |
| Q4 2025 | $2.07 | -1.9% |
| Q3 2025 | $2.04 | -1% |
| Q2 2025 | $1.99 | -2.5% |
| Q1 2025 | $2.04 | +3.6% |
| Q4 2024 | $2.11 | +8.8% |
EXPO earned $2.31 per share over the past year, up 13% from the year before.
EXPO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $173.7M | +18% |
| Q2 2026 | $171.6M | +21% |
| Q1 2026 | $166.3M | +14% |
| Q4 2025 | $147.4M | +7.8% |
| Q3 2025 | $147.1M | +8% |
| Q2 2025 | $142M | +1% |
| Q1 2025 | $145.5M | +0.4% |
| Q4 2024 | $136.8M | +11% |
EXPO's revenue has grown year over year for 11 quarters in a row: $174M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +4.4 points |
| Q2 2026 | 16% | +4.2 points |
| Q1 2026 | 25% | -5.7 points |
| Q4 2025 | 20% | -0.2 points |
| Q3 2025 | 20% | +0.8 points |
| Q2 2025 | 12% | -13 points |
| Q1 2025 | 31% | +9.3 points |
| Q4 2024 | 20% | +5 points |
EXPO's operating margin was 24% last quarter, up 4.4 points from the same quarter a year ago.
EXPO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $62.1M | +107% |
| Q2 2026 | $29.1M | -14% |
| Q1 2026 | -$3.4M | -162% |
| Q4 2025 | $52.9M | -1% |
| Q3 2025 | $30M | +7.1% |
| Q2 2025 | $33.9M | -28% |
| Q1 2025 | $5.5M | -38% |
| Q4 2024 | $53.5M | -23% |
EXPO generated $141M in free cash flow over the past year, up 14% from the year before.
EXPO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -565K shares |
| 1 year | -5.4% | -2.8M shares |
| 3 years | -6.2% | -3.2M shares |
| 5 years | -9.2% | -4.9M shares |
| Available history | -10% | -5.4M shares |
EXPO has 48M diluted shares, down 5.4% from a year ago, with $171M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $67.4M |
| Q1 2026 | $78.8M |
| Q4 2025 | $24.4M |
| Q3 2025 | $40M |
| Q4 2024 | $1,000 |
| Q3 2024 | $1,000 |
| Q2 2024 | $244,000 |
EXPO spent $171M buying back its own shares over the past year.
EXPO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.7x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
EXPO has more cash than debt.
EXPO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.5 | Overbought |
| Stochastic | 82.5 | Overbought |
EXPO's weekly RSI is 73 (overbought) and its Stochastic is 83 (overbought).
EXPO PE vs Industrials Sector
| Metric | EXPO | Sector median | Relative |
|---|---|---|---|
| PE | 37x | 24x | 55% above |
| PE % | 21 | 58 | 37 pts below |
EXPO is trading at 37x earnings, a 55% premium to the Industrials sector's median of 24x.
EXPO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $75.1 | 15% above |
| 20 week MA | $69.7 | 24% above |
| 50 week MA | $68.2 | 27% above |
| 100 week MA | $72.7 | 19% above |
| 200 week MA | $83.0 | 3.9% above |
EXPO has climbed back above all five of its weekly moving averages, and it's now 3.9% above its 200-week average.
EXPO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $69.5 | $88.8 | +28% |
| 2021 | $88.8 | $114.0 | +28% |
| 2022 | $114.0 | $100.6 | -12% |
| 2023 | $100.6 | $88.0 | -12% |
| 2024 | $88.0 | $89.4 | +1.6% |
| 2025 | $89.4 | $71.4 | -20% |
| 2026 YTD | $71.4 | $86.2 | +21% |
EXPO has finished lower in three of the last six years. It's up 21% so far in 2026.